The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial
Abstract
CONTEXT: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting women of reproductive age. Hyperandrogenism is the central feature of PCOS. Studies on isolated ovarian theca-interstitial cells suggest that resveratrol, a natural polyphenol, reduces androgen production. OBJECTIVE: This study was designed to evaluate endocrine and metabolic effects of resveratrol on PCOS. DESIGN AND SETTING: This was a randomized (1:1) double-blind, placebo-controlled trial that evaluated the effects of resveratrol over a period of 3 months in an academic hospital. PATIENTS AND OTHER PARTICIPANTS: Subjects with PCOS were identified according to the Rotterdam criteria. Thirty-four subjects were enrolled and 30 subjects completed the trial. Evaluations were performed at baseline and repeated after 3 months of treatment. INTERVENTION: Resveratrol (1,500 mg p.o.) or placebo were administered daily. MAIN OUTCOME MEASURE: Primary outcome was the change in the serum total T. RESULTS: Resveratrol treatment led to a significant decrease of total T by 23.1% (P = .01). In parallel, resveratrol induced a 22.2% decrease of dehydroepiandrosterone sulfate (P = .01), a decrease of fasting insulin level by 31.8% (P = .007) and an increase of the Insulin Sensitivity Index (Matsuda and DeFronzo) by 66.3% (P = .04). Levels of gonadotropins, the lipid profile as well as markers of inflammation and endothelial function were not significantly altered. CONCLUSIONS: Resveratrol significantly reduced ovarian and adrenal androgens. This effect may be, at least in part, related to an improvement of insulin sensitivity and a decline of insulin level.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a randomized placebo-controlled trial, treatment with 1500 mg daily of resveratrol significantly decreased testosterone and dehydroepiandrosterone sulfate excess by ~23% in PCOS women over a period of 3 months [138].”
From Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases (2020) · cites this paper as [138]
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 1×
“Evaluation of insulin sensitivity using fasting measures used the method described by Katz et al (22): Quantitative Insulin Sensitivity Check Index (QUICKI) 1/[log(fasting insulin) log (fasting glucose)].”
MethodInsulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Asunción, M., Calvo, R. M., Millán, J. L. S., Sancho, J., Ávila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,328
Diamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6148 · Cited by 1,107
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Nelson, V. L., Legro, R. S., Strauss, J. F., & McAllister, J. M. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0311 · Cited by 556
Flagged first, then by citations
Cited by
Sorted by citations
Health benefits of resveratrol: Evidence from clinical studies
Singh, A. P., Singh, R., Verma, S. S., Rai, V., Kaschula, C. H., Maiti, P., & Gupta, S. C. (2019) · Medicinal Research Reviews · doi:10.1002/med.21565 · Cited by 523
Tatone, C., Emidio, G. D., Barbonetti, A., Carta, G., Luciano, A. M., Falone, S., & Amicarelli, F. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy003 · Cited by 296
Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases
Mirabelli, M., Chiefari, E., Arcidiacono, B., Corigliano, D. M., Brunetti, F. S., Maggisano, V., Russo, D., Foti, D. P., & Brunetti, A. (2020) · Nutrients · doi:10.3390/nu12041066 · Cited by 272
“In a randomized placebo-controlled trial, treatment with 1500 mg daily of resveratrol significantly decreased testosterone and dehydroepiandrosterone sulfate excess by ~23% in PCOS women over a period of 3 months [138].”
BackgroundMethodInfluentialAdvances in phytochemical delivery systems for improved anticancer activity
Lagoa, R., Silva, J. S., Rodrigues, J. R., & Bishayee, A. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.04.004 · Cited by 215
Brown, K., Theofanous, D., Britton, R. G., Aburido, G., Pepper, C., Undru, S. S., & Howells, L. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020747 · Cited by 209
Barrea, L., Marzullo, P., Muscogiuri, G., Di Somma, C., Scacchi, M., Orio, F., Aimaretti, G., Colao, A., & Savastano, S. (2018) · Nutrition Research Reviews · doi:10.1017/s0954422418000136 · Cited by 171
MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease
Schiffer, L., Kempegowda, P., Arlt, W., & O’Reilly, M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0124 · Cited by 162
The Mechanism of Androgen Actions in PCOS Etiology
Paris, V. R., & Bertoldo, M. J. (2019) · Medical Sciences · doi:10.3390/medsci7090089 · Cited by 134
The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations
Li, X., Feng, Y., Wang, X.-X., Truong, D., & Wu, Y. (2020) · Aging and Disease · doi:10.14336/ad.2020.0216 · Cited by 134
Brenjian, S., Moini, A., Yamini, N., Kashani, L., Faridmojtahedi, M., Bahramrezaie, M., Khodarahmian, M., & Amidi, F. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13186 · Cited by 128
Clinical Application of Antioxidants to Improve Human Oocyte Mitochondrial Function: A Review
Rodríguez-Varela, C., & Labarta, E. (2020) · Antioxidants · doi:10.3390/antiox9121197 · Cited by 116
Androgens and ovarian function: translation from basic discovery research to clinical impact
Walters, K. A., Rodriguez Paris, V, Aflatounian, A., & Handelsman, D. J. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0096 · Cited by 104
Nutrition in Gynecological Diseases: Current Perspectives
Ciebiera, M., Esfandyari, S., Siblini, H., Prince, L., Elkafas, H., Wojtyła, C., Al-Hendy, A. A., & Ali, M. K. (2021) · Nutrients · doi:10.3390/nu13041178 · Cited by 140
Human Sirtuin Regulators: The “Success” Stories
Curry, A. M., White, D. S., Donu, D., & Cen, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.752117 · Cited by 107
Evidence from animal models on the pathogenesis of PCOS
Walters, K. A., Bertoldo, M. J., & Handelsman, D. J. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.03.008 · Cited by 101
Bouyahya, A., Omari, N. E., Menyiy, N. E., Guaouguaou, F., Balahbib, A., Belmehdi, O., Salhi, N., Imtara, H., Mrabti, H. N., El‐Shazly, M., et al. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.03.032 · Cited by 95
Bahramrezaie, M., Amidi, F., Aleyasin, A., Saremi, A. T., Aghahoseini, M., Brenjian, S., Khodarahmian, M., & Pooladi, A. (2019) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-019-01461-6 · Cited by 97
Gharaei, R., Alyasin, A., Mahdavinezhad, F., Samadian, E., Ashrafnezhad, Z., & Amidi, F. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02432-0 · Cited by 94
Ameliorating Effects of Natural Antioxidant Compounds on Female Infertility: a Review
Bhardwaj, J. K., Panchal, H., & Saraf, P. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00312-5 · Cited by 96
Haghighatdoost, F., & Hariri, M. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.033 · Cited by 88
The Importance of Natural Antioxidants in Female Reproduction
Vašková, J., Klepcová, Z., Špaková, I., Urdzík, P., Štofilová, J., Bertková, I., Kľoc, M., & Rabajdová, M. (2023) · Antioxidants · doi:10.3390/antiox12040907 · Cited by 101
Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
Brockmueller, A., Sameri, S., Líšková, A., Zhai, K., Varghese, E., Samuel, S. M., Büsselberg, D., Kubatka, P., & Shakibaei, M. (2021) · Cancers · doi:10.3390/cancers13020188 · Cited by 89
Resveratrol: A Review on the Biological Activity and Applications
Bejenaru, L. E., Biţă, A., Belu, I., Segneanu, A., Radu, A., Dumitru, A., Ciocîlteu, M. V., Mogoşanu, G. D., & Bejenaru, C. (2024) · Applied Sciences · doi:10.3390/app14114534 · Cited by 94
Józkowiak, M., Hutchings, G., Jankowski, M., Kulcenty, K. I., Mozdziak, P. E., Kempisty, B., Spaczyński, R., & Piotrowska‐Kempisty, H. (2020) · Cells · doi:10.3390/cells9061418 · Cited by 74
Fox, C. W., Zhang, L., Sohni, A., Doblado, M., Wilkinson, M., Chang, R. J., & Dulęba, A. J. (2019) · Endocrinology · doi:10.1210/en.2019-00588 · Cited by 78
Karimi, A., Tutunchi, H., Naeini, F., Vajdi, M., Mobasseri, M., & Najafipour, F. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13698 · Cited by 74
Endocrine Disrupting Chemicals, Hormone Receptors, and Acne Vulgaris: A Connecting Hypothesis
Rao, A., Douglas, S. C., & Hall, J. M. (2021) · Cells · doi:10.3390/cells10061439 · Cited by 74
Mousavi, S. M., Milajerdi, A., Sheikhi, A., Kord‐Varkaneh, H., Feinle‐Bisset, C., Larijani, B. A., & Esmaillzadeh, A. (2018) · Obesity Reviews · doi:10.1111/obr.12775 · Cited by 69
Preconception resveratrol intake against infertility: Friend or foe?
Ochiai, A., & Kuroda, K. (2019) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12303 · Cited by 66
Ochiai, A., Kuroda, K., Ozaki, R., Ikemoto, Y., Murakami, K., Muter, J., Matsumoto, A., Itakura, A., Brosens, J. J., & Takeda, S. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1511-7 · Cited by 62
Mansour, A., Samadi, M., Sanginabadi, M., Gerami, H., Karimi, S., Hosseini, S., Shirzad, N., Hekmatdoost, A., Mahdavi‐Gorabi, A., Mohajeri‐Tehrani, M. R., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.004 · Cited by 61
González, F., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa108 · Cited by 60
Qasem, R. J. (2020) · Critical Reviews in Toxicology · doi:10.1080/10408444.2020.1762538 · Cited by 66
Polyphenols: Natural compounds with promising potential in treating polycystic ovary syndrome
Mihanfar, A., Nouri, M., Roshangar, L., & Ansari, M. H. K. (2021) · Reproductive Biology · doi:10.1016/j.repbio.2021.100500 · Cited by 58
Kazemi, M., Jarrett, B. Y., Vanden Brink, H., Lin, A. W., Hoeger, K. M., Spandorfer, S. D., & Lujan, M. E. (2020) · Nutrients · doi:10.3390/nu12071953 · Cited by 53
Saleem, F., & Rizvi, S. W. (2017) · Cureus · doi:10.7759/cureus.1844 · Cited by 56
Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome
Mihanfar, A., Nouri, M., Roshangar, L., & Ansari, M. H. K. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105954 · Cited by 48
Advancements in lead therapeutic phytochemicals polycystic ovary syndrome: A review
Luo, E., Jiang, H., Chen, W., Wang, Y., Tang, M., Guo, W., Diao, H., Cai, N.-Y., Yang, X., Bian, Y., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1065243 · Cited by 54
Resveratrol and Reproductive Health
Novaković, R., Rajković, J., Gostimirović, M., Gojković‐Bukarica, L., & Radunović, N. V. (2022) · Life · doi:10.3390/life12020294 · Cited by 47
Marti, N., Bouchoucha, N., Sauter, K., & Flück, C. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174224 · Cited by 46
Resveratrol supplementation and type 2 diabetes: a systematic review and meta-analysis
Delpino, F. M., & Figueiredo, L. M. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1875980 · Cited by 48
Clinical and Biochemical Potential of Antioxidants in Treating Polycystic Ovary Syndrome
Cheng, X., & He, B. (2022) · International Journal of Women s Health · doi:10.2147/ijwh.s345853 · Cited by 45
Sudhakaran, G., Guru, A., Haridevamuthu, B., Murugan, R., Arshad, A., & Arockiaraj, J. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120276 · Cited by 47
Hypoxia: Role of SIRT1 and the protective effect of resveratrol in ovarian function
Nishigaki, A., Tsubokura, H., Tsuzuki‐Nakao, T., & Okada, H. (2021) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12428 · Cited by 42
Ardehjani, N. A., Aghahosseini, M., Nashtaei, M. S., Khodarahmian, M., Shabani, M., Jabarpour, M., Fereidouni, F., Rastegar, T., & Amidi, F. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01470-9 · Cited by 47
Ji, S., Fattahi, A., Raffel, N., Hoffmann, I., Beckmann, M. W., Dittrich, R., & Schrauder, M. G. (2017) · European journal of medical research · doi:10.1186/s40001-017-0293-6 · Cited by 40
Rani, R., Hajam, Y. A., Kumar, R., Bhat, R. A., Rai, S., & Rather, M. A. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100161 · Cited by 45
Miragem, A. A., & de Bittencourt, P. I. H. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx020 · Cited by 39
Hypoglycemic Effect of Resveratrol: A Systematic Review and Meta-Analysis
García-Martínez, B. I., Ruíz-Ramos, M., Pedraza‐Chaverrí, J., Santiago‐Osorio, E., & Mendoza-Núñez, V. M. (2021) · Antioxidants · doi:10.3390/antiox10010069 · Cited by 38
Effects of phytoestrogens on reproductive organ health
Krishna, S. S., Kuriakose, B. B., & Lakshmi, P. K. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01417-y · Cited by 38
Mohammadipoor, N., Shafiee, F., Rostami, A., Kahrizi, M. S., Soleimanpour‐Lichaei, H. R., Ghodsi, M., Ansari, M. J., Bokov, D. O., Jannat, B., Mosharkesh, E., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7562 · Cited by 38
Rashid, R., Tripathi, R., Singh, A., Sarkar, S., Kawale, A. K., Bader, G. N., Gupta, S., Gupta, R., & Jha, R. K. (2023) · Phytotherapy Research · doi:10.1002/ptr.7860 · Cited by 36
Tarkesh, F., Jahromi, B. N., Hejazi, N., & Tabatabaee, H. (2020) · Food Science & Nutrition · doi:10.1002/fsn3.1837 · Cited by 37
Fadlalmola, H. A., Elhusein, A. M., Al‐Sayaghi, K. M., Albadrani, M. S., Swamy, D. S. V., Mamanao, D. M., El-Amin, E. I., Ibrahim, S. E., & Abbas, S. M. (2023) · Pan African Medical Journal · doi:10.11604/pamj.2023.44.134.32404 · Cited by 38
Anti-cancer perspectives of resveratrol: a comprehensive review
Anwar, M. J., Altaf, A., Imran, M., Amir, M., Alsagaby, S. A., Abdulmonem, W. A., Mujtaba, A., El-Ghorab, A. H., Ghoneim, M. M., Hussain, M., et al. (2023) · Food and Agricultural Immunology · doi:10.1080/09540105.2023.2265686 · Cited by 36
Polycystic ovary syndrome (PCOS) and oxidative stress
Sengupta, P., Dutta, S., & Hassan, M. F. (2024) · Journal of Integrated Science and Technology · doi:10.62110/sciencein.jist.2024.v12.752 · Cited by 37
Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome
Banaszewska, B., Pawelczyk, L. A., & Spaczyński, R. (2019) · Reproductive Biology · doi:10.1016/j.repbio.2019.09.006 · Cited by 33
Self-citationGharaei, R., Mahdavinezhad, F., Samadian, E., Asadi, J., Ashrafnezhad, Z., Kashani, L., & Amidi, F. (2021) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-021-02342-7 · Cited by 39
The Effect on Inflammation of Adherence to the Mediterranean Diet in Polycystic Ovary Syndrome
Dazıroğlu, M. E. Ç., & Tek, N. A. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00451-6 · Cited by 32
Yan, S., Gao, Z., Ding, J., Chen, S., Wang, Z., Jin, W., Qu, B., Zhang, Y., Yang, L., Guo, D., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02182-w · Cited by 35
Sirtuins—The New Important Players in Women’s Gynecological Health
Kratz, E. M., Kokot, I., Dymicka-Piekarska, V., & Piwowar, A. (2021) · Antioxidants · doi:10.3390/antiox10010084 · Cited by 28
Tailoring treatment for PCOS phenotypes
Papadakis, G. E., Kandaraki, E., Garidou, A., Koutsaki, M., Papalou, O., Diamanti‐Kandarakis, E., & Peppa, Μ. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1865152 · Cited by 30
Qorbani, M., Sanginabadi, M., Mohajeri‐Tehrani, M. R., Karimi, S., Gerami, H., Mahdavi‐Gorabi, A., Shirzad, N., Samadi, M., Baygi, F., Hosseini, S., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.590392 · Cited by 26
Tarkesh, F., Jahromi, B. N., Hejazi, N., & Hoseini, G. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01825-8 · Cited by 27
Hassan, S., Shah, M., Malik, M. O., Ehtesham, E., Habib, S. H., & Rauf, B. (2022) · Endocrine · doi:10.1007/s12020-022-03198-2 · Cited by 27
Insights on the NF-κB system in polycystic ovary syndrome, attractive therapeutic targets
Tan, W., Zhang, J., Dai, F., Yang, D., Gu, R., Tang, L., Liu, H., & Cheng, Y. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04736-w · Cited by 25
Clinical applications and mechanism insights of natural flavonoids against type 2 diabetes mellitus
Bouyahya, A., Balahbib, A., Khalid, A., Makeen, H. A., Alhazmi, H. A., Albratty, M., Hermansyah, A., Ming, L. C., Goh, K. W., & Omari, N. E. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29718 · Cited by 25
Resveratrol: Potential Application in Sepsis
Li, J., Zeng, X., Yang, F., Wang, L., Luo, X., Liu, R., Zeng, F., Lu, S., Huang, X., Yu, L., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.821358 · Cited by 25
Are the cardioprotective effects of the phytoestrogen resveratrol sex-dependent?
Louis, X. L., Raj, P., Chan, L., Zieroth, S. R., Netticadan, T., & Wigle, J. T. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0544 · Cited by 26
Sun, S., Jiao, M., Han, C., Zhang, Q., Shi, W., Shi, J., & Li, X. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00621 · Cited by 23
Yang, K., Zeng, L., Bao, T., Long, Z., & Jin, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-54408-3 · Cited by 23
Shojaei‐Zarghani, S., & Rafraf, M. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00653-9 · Cited by 23
Molecular Mechanism of Resveratrol and Its Therapeutic Potential on Female Infertility
Podgrajšek, R., Frangež, H. B., & Štimpfel, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073613 · Cited by 22
The Role of Androgen Excess on Insulin Sensitivity in Women
Diamanti‐Kandarakis, E., Papalou, O., & Kandaraki, E. (2019) · Frontiers of hormone research · doi:10.1159/000494902 · Cited by 22
Huo, P., Li, M., Le, J., Zhu, C., Yao, J., & Zhang, S. (2022) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2022.2125855 · Cited by 20
Chavez, G. N., Jaworsky, K., & Basu, A. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20156534 · Cited by 22
He, J., Deng, R., Wei, Y., Zhang, S., Su, M., Tang, M., Wang, J., Nong, W., & Lei, X. (2024) · Food & Function · doi:10.1039/d3fo02824k · Cited by 22
Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes
Ortiz-Flores, A. E., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1528231 · Cited by 20
Kargozar, R., Salari, R., Jarahi, L., Yousefi, M., Pourhoseini, S. A., Sahebkar-Khorasani, M., & Azizi, H. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.04.003 · Cited by 21
Liu, X., Zeng, T., Zhang, E., Bin, C., Liu, Q., Wu, K., Luo, Y., & Wei, S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1650347 · Cited by 26
Zanjirband, M., Baharlooie, M., Safaeinejad, Z., & Nasr‐Esfahani, M. H. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106601 · Cited by 18
Updates on molecular and environmental determinants of luteal progesterone production
DeWitt, N. A., Whirledge, S., & Kallen, A. N. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110930 · Cited by 17
Association between sex steroid hormones and subsequent hyperglycemia during pregnancy
Meng, Y., Thornburg, L. L., Hoeger, K. M., Rivera‐Núñez, Z., Kautz, A., Evans, A. T., Wang, C., Miller, R. K., Groth, S. W., O’Connor, T. G., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1213402 · Cited by 18
Taheri, A. P. H., Moradi, B., Radmard, A. R., Sanginabadi, M., Qorbani, M., Mohajeri‐Tehrani, M. R., Shirzad, N., Hosseini, S., Hekmatdoost, A., Asadi, S., et al. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521003330 · Cited by 16
Larik, M. O., Ahmed, A., Khan, L., & Iftekhar, M. A. (2023) · Endocrine · doi:10.1007/s12020-023-03479-4 · Cited by 16
Effect and mechanism of resveratrol against polycystic ovary syndrome: a review
Chang, H., Shi, B., Wang, Y., Lu, F., Guan, M., & Wu, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1529231 · Cited by 16
Stilbenoids: Chemistry, occurrence, bioavailability and health effects—a review
Oh, W. Y., Gao, Y., & Shahidi, F. (2021) · Journal of Food Bioactives · doi:10.31665/jfb.2020.13256 · Cited by 16
Effect of resveratrol on superovulation in mice
Li, R., Li, E., Kamili, G., Ou, S., & Yang, D. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112565 · Cited by 14
Ibuprofen Reduces Testosterone Level in Women With Polycystic Ovary Syndrome
Banaszewska, B., Ożegowska, K., Polska, M., Pawelczyk, L. A., Chang, R. J., & Dulęba, A. J. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac128 · Cited by 14
Self-citationBalieiro, C. C. A., Hespanhol, L. C., Fonseca, L. M., Wantowski, S., Freitas, M. A. A., Dias, Y. J. M., Burlá, M. M., & de Oliveira, L. M. L. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2023.12.038 · Cited by 13
González, F., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2020) · Human Reproduction · doi:10.1093/humrep/deaa056 · Cited by 13
Ibuprofen inhibits key genes involved in androgen production in theca–interstitial cells
Fox, C. W., Zhang, L., Moeller, B. C., Garzo, V. G., Chang, R. J., & Dulęba, A. J. (2021) · F&S Science · doi:10.1016/j.xfss.2021.06.004 · Cited by 15
Saavedra-Leos, M. Z., Jordan‐Alejandre, E., López‐Camarillo, C., Pozos‐Guillén, A., Leyva‐Porras, C., & Silva-Cázares, M. B. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.664380 · Cited by 14
Pharmacologic Treatment of Polycystic Ovary Syndrome: Alternate and Future Paths
Legro, R. S., & Martel‐Duguech, L. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1603729 · Cited by 11
The Journey of Resveratrol from Vineyards to Clinics
Venkat, R., Verma, E., Daimary, U. D., Kumar, A., Girisa, S., Dutta, U., Ahn, K. S., & Kunnumakkara, A. B. (2022) · Cancer Investigation · doi:10.1080/07357907.2022.2115057 · Cited by 12
González, F., Mather, K. J., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00228.2020 · Cited by 12
Effects of resveratrol on female reproduction: A review
Sirotkin, A. V. (2021) · Phytotherapy Research · doi:10.1002/ptr.7185 · Cited by 11
Zhu, S., Chen, H., He, B., Zhang, Y., Li, P., & Kuang, J. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1659783 · Cited by 14
Harnessing SIRT1 activators for effective PCOS treatment: A new frontier
Moharir, S. R., Talamadla, M. K., Bhardwaj, P., Banerjee, A., Dey, R. J., & Sekhar, K. V. G. C. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118361 · Cited by 11
Role of the AMP-Activated Protein Kinase in the Pathogenesis of Polycystic Ovary Syndrome
Jalil, A. T., Zair, M. A., Hanthal, Z. R., Naser, S. J., Aslandook, T., Abosaooda, M., & Fadhil, A. A. (2023) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-023-01139-y · Cited by 9
Metadata
- Authors
- Banaszewska, B., Wrotyńska-Barczyńska, J., Spaczynski, R. Z., Pawelczyk, L., & Duleba, A. J.
- Affiliations
- Poznan University of Medical Sciences (PL)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-11
- Volume
- 101
- Issue
- 11
- Pages
- 4322-4328
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2532986090
- Cited by
- 173
- References
- 35
- Citations by year
- 2026: 21 · 2025: 14 · 2024: 22 · 2023: 23 · 2022: 23 · 2021: 24 · 2020: 16 · 2019: 17 · 2018: 7 · 2017: 6
- FWCI
- 13.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- resveratrol, polycystic ovary syndrome, hyperandrogenism, serum total testosterone, dehydroepiandrosterone sulfate, insulin sensitivity, fasting insulin, insulin resistance, insulin-like growth factor I, ovarian androgen production, adrenal androgens, lipid profile, inflammation, endothelial function
- MeSH terms
- Resveratrol, Adult, Antioxidants, Double-Blind Method, Female, Humans, Insulin, Insulin Resistance, Polycystic Ovary Syndrome, Stilbenes, Testosterone, Outcome Assessment, Health Care, Dehydroepiandrosterone Sulfate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
